The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Pfizer
Exposure toxicity and response relationship of cabozantinib (CABO) in patients with metastatic renal cell carcinoma (mRCC).
 
Alexandre Xu-Vuillard
No Relationships to Disclose
 
Anne Jouinot
No Relationships to Disclose
 
Thomas Pudlarz
No Relationships to Disclose
 
Benoit Blanchet
Honoraria - Bristol-Myers Squibb; Janssen; Leo Pharma; Pierre Fabre; Promise
 
Olivier Huillard
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; MSD; MSD; Pfizer; Sanofi
Travel, Accommodations, Expenses - Ipsen
 
Charlotte Joly
No Relationships to Disclose
 
Christophe Tournigand
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Consulting or Advisory Role - Bayer
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; MSD; Roche
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi
Research Funding - Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche
 
Jacques Medioni
Consulting or Advisory Role - Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Pfizer
Travel, Accommodations, Expenses - Lilly; Pfizer; Seagen
 
Yann-Alexandre Vano
No Relationships to Disclose